InforMax Promotes Stephen Lincoln To Chief Scientific Officer | GenomeWeb

NEW YORK, May 1 – InforMax has promoted Stephen Lincoln to executive vice president, product development and chief scientific officer, the company said Tuesday.

Concurrent with Lincoln’s promotion, InforMax said that Vadim Babenko, the company’s chief technology officer, would step down and instead provide advisory services for the company.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nucleic Acids Research this week: transcriptome patterns of Zika-infected cells, updated Comparative Toxicogenomics Database, and more.

BMJ study says that about half of former hematology-oncology regulators now work for industry.

Science should wish PhDs who leave academia well, a Nature editorial says.

New York-based doctors announce the birth of a baby boy whose parents underwent mitochondrial transfer therapy, New Scientist reports.